MENU

Fox Chase Cancer Center News

Dr. Martin Edelman
May 29, 2020

Fox Chase Researcher Leads International Study Evaluating Treatment of Small Cell Lung Cancer Using Dinutuximab

PHILADELPHIA (May 29, 2020)— The study ultimately concluded that treatment with dinutuximab plus irinotecan was not superior to the established second-line treatment for relapsed/refractory small cell lung cancer.

Dr. Martin Edelman
May 29, 2020

Fox Chase Researchers Investigate Marrow Infiltrating Lymphocytes in Treating Non-Small Cell Lung Cancer

PHILADELPHIA (May 29, 2020) — After earlier research found that the same lymphocytes that can treat a tumor are also present in bone marrow, Fox Chase became one of the first institutions to open a trial investigating the effectiveness of using marrow infiltrating lymphocytes for the treatment of NSCLC.

May 29, 2020

Fox Chase Researchers Underscore Efficacy of Pembrolizumab Plus Axitinib in Treating Advanced Renal Cell Carcinoma

PHILADELPHIA (May 29, 2020)—Pembrolizumab (Keytruda) in combination with axitinib (Inlyta) continues to show improved efficacy in the treatment of advanced renal cell carcinoma when compared with the use of sunitinib (Sutent).

Lauren Zimmaro, PhD, lead author
May 28, 2020

Fox Chase Researchers Investigate Perceived Barriers to Discussing Sexual Issues in Breast Cancer Patients

PHILADELPHIA (May 28, 2020)—Breast cancer patients describe having thoughts and feelings that can prevent them from discussing cancer-related sexual issues with their healthcare providers, even if they would like to.

Eric D. Tetzlaff, MHS, PA-C, DFAAPA
May 20, 2020

Fox Chase Researchers Find Increase in Burnout Among Oncology Physician Assistants

PHILADELPHIA (May 20, 2020) — According to the 2019 national survey, 48.7 percent of oncology physician assistants reported burnout, as opposed to 34.8 percent in 2015.

May 18, 2020

Fox Chase Recognized by Life Sciences Pennsylvania for Pioneering New Technology in Lung Cancer Diagnosis

PHILADELPHIA (May 18, 2020)—Fox Chase was recognized for its use of the Monarch Platform, a technology that features a familiar controller-like interface that physicians use to navigate a flexible robotic endoscope to the periphery of the lung. The technology improves reach, vision, and control.

May 14, 2020

Fox Chase Cancer Center Highlights the Signs of Skin Cancer and How to Protect Skin from Sun Damage

PHILADELPHIA (May 14, 2020) – May is Skin Cancer Prevention Month.  The two most common types of skin cancers, basal cell and squamous cell skin cancers, are usually very treatable and most commonly found in areas exposed to the sun.

Namrata Vijayvergia, MD
May 11, 2020

Fox Chase Researchers Examine Role of Pembrolizumab in Treating Patients With Metastatic Neuroendocrine Tumors

PHILADELPHIA (May 11, 2020) — Combination strategies targeting the immune checkpoint pathway from multiple angles may be the key. A recent study suggested the benefit of two immune checkpoint drugs, which showed promising response in this rare cancer.

Pages

Connect with Fox Chase